検体妥当性試験の世界市場 2020年

• 英文タイトル：Global Specimen Validity Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115187 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：サービス・ソフトウェア

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、検体妥当性試験の世界市場を調査対象にし、検体妥当性試験の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ラボ検査、迅速/POC検査）、用途別分析（職場、薬物スクリーニング研究所、刑事司法・法執行機関、疼痛管理センター、薬物リハビリセンター、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Thermo Fisher (US)、Quest Diagnostics (US)、Alere (US)、Sciteck. (US)、LabCorp (US)、American Bio Medica Corporation (ABMC)、ACM Global Laboratories (US)、Premier Biotech (US)、Express Diagnostics (US)、Alere Toxicology (US)、Clinical Reference Laboratory (CRL) (US)、SureHire (Canada)、CannAmm (Canada) ・企業別売上、市場シェア ・検体妥当性試験の地域別市場分析 ・検体妥当性試験の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・検体妥当性試験のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・検体妥当性試験のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・検体妥当性試験の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・検体妥当性試験の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・検体妥当性試験の種類別市場規模2015-2020：ラボ検査、迅速/POC検査 ・検体妥当性試験の用途別市場規模2015-2020：職場、薬物スクリーニング研究所、刑事司法・法執行機関、疼痛管理センター、薬物リハビリセンター、その他 ・検体妥当性試験の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Specimen Validity Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1136.1 million by 2025, from USD 993.1 million in 2019.

The Specimen Validity Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Specimen Validity Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Specimen Validity Testing market has been segmented into:
Laboratory Testing
Rapid/POC Testing

By Application, Specimen Validity Testing has been segmented into:
Workplaces
Drug Screening Laboratories
Criminal Justice and Law Enforcement Agencies
Pain Management Centers
Drug Rehabilitation Centers
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Specimen Validity Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Specimen Validity Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Specimen Validity Testing market.

The report offers in-depth assessment of the growth and other aspects of the Specimen Validity Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Specimen Validity Testing Market Share Analysis
Specimen Validity Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Specimen Validity Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Specimen Validity Testing sales, revenue and market share for each player covered in this report.

The major players covered in Specimen Validity Testing are:
Thermo Fisher (US)
Quest Diagnostics (US)
Alere (US)
Sciteck. (US)
LabCorp (US)
American Bio Medica Corporation (ABMC)
ACM Global Laboratories (US)
Premier Biotech (US)
Express Diagnostics (US)
Alere Toxicology (US)
Clinical Reference Laboratory (CRL) (US)
SureHire (Canada)
CannAmm (Canada)

レポート目次

---

Table of Contents

1 Specimen Validity Testing Market Overview
1.1 Product Overview and Scope of Specimen Validity Testing
1.2 Classification of Specimen Validity Testing by Type
1.2.1 Global Specimen Validity Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Specimen Validity Testing Revenue Market Share by Type in 2019
1.2.3 Laboratory Testing
1.2.4 Rapid/POC Testing
1.3 Global Specimen Validity Testing Market by Application
1.3.1 Overview: Global Specimen Validity Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Workplaces
1.3.3 Drug Screening Laboratories
1.3.4 Criminal Justice and Law Enforcement Agencies
1.3.5 Pain Management Centers
1.3.6 Drug Rehabilitation Centers
1.3.7 Others
1.4 Global Specimen Validity Testing Market by Regions
1.4.1 Global Specimen Validity Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Specimen Validity Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Specimen Validity Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Specimen Validity Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Specimen Validity Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Specimen Validity Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Specimen Validity Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher (US)
2.1.1 Thermo Fisher (US) Details
2.1.2 Thermo Fisher (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher (US) SWOT Analysis
2.1.4 Thermo Fisher (US) Product and Services
2.1.5 Thermo Fisher (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Quest Diagnostics (US)
2.2.1 Quest Diagnostics (US) Details
2.2.2 Quest Diagnostics (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Quest Diagnostics (US) SWOT Analysis
2.2.4 Quest Diagnostics (US) Product and Services
2.2.5 Quest Diagnostics (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Alere (US)
2.3.1 Alere (US) Details
2.3.2 Alere (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Alere (US) SWOT Analysis
2.3.4 Alere (US) Product and Services
2.3.5 Alere (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sciteck. (US)
2.4.1 Sciteck. (US) Details
2.4.2 Sciteck. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sciteck. (US) SWOT Analysis
2.4.4 Sciteck. (US) Product and Services
2.4.5 Sciteck. (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 LabCorp (US)
2.5.1 LabCorp (US) Details
2.5.2 LabCorp (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 LabCorp (US) SWOT Analysis
2.5.4 LabCorp (US) Product and Services
2.5.5 LabCorp (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 American Bio Medica Corporation (ABMC)
2.6.1 American Bio Medica Corporation (ABMC) Details
2.6.2 American Bio Medica Corporation (ABMC) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 American Bio Medica Corporation (ABMC) SWOT Analysis
2.6.4 American Bio Medica Corporation (ABMC) Product and Services
2.6.5 American Bio Medica Corporation (ABMC) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 ACM Global Laboratories (US)
2.7.1 ACM Global Laboratories (US) Details
2.7.2 ACM Global Laboratories (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 ACM Global Laboratories (US) SWOT Analysis
2.7.4 ACM Global Laboratories (US) Product and Services
2.7.5 ACM Global Laboratories (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Premier Biotech (US)
2.8.1 Premier Biotech (US) Details
2.8.2 Premier Biotech (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Premier Biotech (US) SWOT Analysis
2.8.4 Premier Biotech (US) Product and Services
2.8.5 Premier Biotech (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Express Diagnostics (US)
2.9.1 Express Diagnostics (US) Details
2.9.2 Express Diagnostics (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Express Diagnostics (US) SWOT Analysis
2.9.4 Express Diagnostics (US) Product and Services
2.9.5 Express Diagnostics (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Alere Toxicology (US)
2.10.1 Alere Toxicology (US) Details
2.10.2 Alere Toxicology (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Alere Toxicology (US) SWOT Analysis
2.10.4 Alere Toxicology (US) Product and Services
2.10.5 Alere Toxicology (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Clinical Reference Laboratory (CRL) (US)
2.11.1 Clinical Reference Laboratory (CRL) (US) Details
2.11.2 Clinical Reference Laboratory (CRL) (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Clinical Reference Laboratory (CRL) (US) SWOT Analysis
2.11.4 Clinical Reference Laboratory (CRL) (US) Product and Services
2.11.5 Clinical Reference Laboratory (CRL) (US) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.12 SureHire (Canada)
2.12.1 SureHire (Canada) Details
2.12.2 SureHire (Canada) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 SureHire (Canada) SWOT Analysis
2.12.4 SureHire (Canada) Product and Services
2.12.5 SureHire (Canada) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
2.13 CannAmm (Canada)
2.13.1 CannAmm (Canada) Details
2.13.2 CannAmm (Canada) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 CannAmm (Canada) SWOT Analysis
2.13.4 CannAmm (Canada) Product and Services
2.13.5 CannAmm (Canada) Specimen Validity Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Specimen Validity Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Specimen Validity Testing Players Market Share
3.2.2 Top 10 Specimen Validity Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Specimen Validity Testing Revenue and Market Share by Regions
4.2 North America Specimen Validity Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Specimen Validity Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Specimen Validity Testing Revenue and Growth Rate (2015-2020)
4.5 South America Specimen Validity Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Specimen Validity Testing Revenue and Growth Rate (2015-2020)
5 North America Specimen Validity Testing Revenue by Countries
5.1 North America Specimen Validity Testing Revenue by Countries (2015-2020)
5.2 USA Specimen Validity Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Specimen Validity Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Specimen Validity Testing Revenue and Growth Rate (2015-2020)
6 Europe Specimen Validity Testing Revenue by Countries
6.1 Europe Specimen Validity Testing Revenue by Countries (2015-2020)
6.2 Germany Specimen Validity Testing Revenue and Growth Rate (2015-2020)
6.3 UK Specimen Validity Testing Revenue and Growth Rate (2015-2020)
6.4 France Specimen Validity Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Specimen Validity Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Specimen Validity Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Specimen Validity Testing Revenue by Countries
7.1 Asia-Pacific Specimen Validity Testing Revenue by Countries (2015-2020)
7.2 China Specimen Validity Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Specimen Validity Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Specimen Validity Testing Revenue and Growth Rate (2015-2020)
7.5 India Specimen Validity Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Specimen Validity Testing Revenue and Growth Rate (2015-2020)
8 South America Specimen Validity Testing Revenue by Countries
8.1 South America Specimen Validity Testing Revenue by Countries (2015-2020)
8.2 Brazil Specimen Validity Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Specimen Validity Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Specimen Validity Testing by Countries
9.1 Middle East & Africa Specimen Validity Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Specimen Validity Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Specimen Validity Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Specimen Validity Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Specimen Validity Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Specimen Validity Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Specimen Validity Testing Market Forecast by Type (2019-2024)
10.3 Laboratory Testing Revenue Growth Rate (2015-2025)
10.4 Rapid/POC Testing Revenue Growth Rate (2015-2025)
11 Global Specimen Validity Testing Market Segment by Application
11.1 Global Specimen Validity Testing Revenue Market Share by Application (2015-2020)
11.2 Specimen Validity Testing Market Forecast by Application (2019-2024)
11.3 Workplaces Revenue Growth (2015-2020)
11.4 Drug Screening Laboratories Revenue Growth (2015-2020)
11.5 Criminal Justice and Law Enforcement Agencies Revenue Growth (2015-2020)
11.6 Pain Management Centers Revenue Growth (2015-2020)
11.7 Drug Rehabilitation Centers Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Specimen Validity Testing Market Size Forecast (2021-2025)
12.1 Global Specimen Validity Testing Market Size Forecast (2021-2025)
12.2 Global Specimen Validity Testing Market Forecast by Regions (2021-2025)
12.3 North America Specimen Validity Testing Revenue Market Forecast (2021-2025)
12.4 Europe Specimen Validity Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Specimen Validity Testing Revenue Market Forecast (2021-2025)
12.6 South America Specimen Validity Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Specimen Validity Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Specimen Validity Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Specimen Validity Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Specimen Validity Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Specimen Validity Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher (US) Corporate Information, Location and Competitors
Table 6. Thermo Fisher (US) Specimen Validity Testing Major Business
Table 7. Thermo Fisher (US) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher (US) SWOT Analysis
Table 9. Thermo Fisher (US) Specimen Validity Testing Product and Solutions
Table 10. Thermo Fisher (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Quest Diagnostics (US) Corporate Information, Location and Competitors
Table 12. Quest Diagnostics (US) Specimen Validity Testing Major Business
Table 13. Quest Diagnostics (US) Specimen Validity Testing Total Revenue (USD Million) (2018-2019)
Table 14. Quest Diagnostics (US) SWOT Analysis
Table 15. Quest Diagnostics (US) Specimen Validity Testing Product and Solutions
Table 16. Quest Diagnostics (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Alere (US) Corporate Information, Location and Competitors
Table 18. Alere (US) Specimen Validity Testing Major Business
Table 19. Alere (US) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 20. Alere (US) SWOT Analysis
Table 21. Alere (US) Specimen Validity Testing Product and Solutions
Table 22. Alere (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Sciteck. (US) Corporate Information, Location and Competitors
Table 24. Sciteck. (US) Specimen Validity Testing Major Business
Table 25. Sciteck. (US) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 26. Sciteck. (US) SWOT Analysis
Table 27. Sciteck. (US) Specimen Validity Testing Product and Solutions
Table 28. Sciteck. (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. LabCorp (US) Corporate Information, Location and Competitors
Table 30. LabCorp (US) Specimen Validity Testing Major Business
Table 31. LabCorp (US) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 32. LabCorp (US) SWOT Analysis
Table 33. LabCorp (US) Specimen Validity Testing Product and Solutions
Table 34. LabCorp (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. American Bio Medica Corporation (ABMC) Corporate Information, Location and Competitors
Table 36. American Bio Medica Corporation (ABMC) Specimen Validity Testing Major Business
Table 37. American Bio Medica Corporation (ABMC) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 38. American Bio Medica Corporation (ABMC) SWOT Analysis
Table 39. American Bio Medica Corporation (ABMC) Specimen Validity Testing Product and Solutions
Table 40. American Bio Medica Corporation (ABMC) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. ACM Global Laboratories (US) Corporate Information, Location and Competitors
Table 42. ACM Global Laboratories (US) Specimen Validity Testing Major Business
Table 43. ACM Global Laboratories (US) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 44. ACM Global Laboratories (US) SWOT Analysis
Table 45. ACM Global Laboratories (US) Specimen Validity Testing Product and Solutions
Table 46. ACM Global Laboratories (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Premier Biotech (US) Corporate Information, Location and Competitors
Table 48. Premier Biotech (US) Specimen Validity Testing Major Business
Table 49. Premier Biotech (US) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 50. Premier Biotech (US) SWOT Analysis
Table 51. Premier Biotech (US) Specimen Validity Testing Product and Solutions
Table 52. Premier Biotech (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Express Diagnostics (US) Corporate Information, Location and Competitors
Table 54. Express Diagnostics (US) Specimen Validity Testing Major Business
Table 55. Express Diagnostics (US) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 56. Express Diagnostics (US) SWOT Analysis
Table 57. Express Diagnostics (US) Specimen Validity Testing Product and Solutions
Table 58. Express Diagnostics (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Alere Toxicology (US) Corporate Information, Location and Competitors
Table 60. Alere Toxicology (US) Specimen Validity Testing Major Business
Table 61. Alere Toxicology (US) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 62. Alere Toxicology (US) SWOT Analysis
Table 63. Alere Toxicology (US) Specimen Validity Testing Product and Solutions
Table 64. Alere Toxicology (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Clinical Reference Laboratory (CRL) (US) Corporate Information, Location and Competitors
Table 66. Clinical Reference Laboratory (CRL) (US) Specimen Validity Testing Major Business
Table 67. Clinical Reference Laboratory (CRL) (US) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 68. Clinical Reference Laboratory (CRL) (US) SWOT Analysis
Table 69. Clinical Reference Laboratory (CRL) (US) Specimen Validity Testing Product and Solutions
Table 70. Clinical Reference Laboratory (CRL) (US) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. SureHire (Canada) Corporate Information, Location and Competitors
Table 72. SureHire (Canada) Specimen Validity Testing Major Business
Table 73. SureHire (Canada) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 74. SureHire (Canada) SWOT Analysis
Table 75. SureHire (Canada) Specimen Validity Testing Product and Solutions
Table 76. SureHire (Canada) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. CannAmm (Canada) Corporate Information, Location and Competitors
Table 78. CannAmm (Canada) Specimen Validity Testing Major Business
Table 79. CannAmm (Canada) Specimen Validity Testing Total Revenue (USD Million) (2017-2018)
Table 80. CannAmm (Canada) SWOT Analysis
Table 81. CannAmm (Canada) Specimen Validity Testing Product and Solutions
Table 82. CannAmm (Canada) Specimen Validity Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Specimen Validity Testing Revenue (Million USD) by Players (2015-2020)
Table 84. Global Specimen Validity Testing Revenue Share by Players (2015-2020)
Table 85. Global Specimen Validity Testing Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Specimen Validity Testing Revenue Market Share by Regions (2015-2020)
Table 87. North America Specimen Validity Testing Revenue by Countries (2015-2020)
Table 88. North America Specimen Validity Testing Revenue Market Share by Countries (2015-2020)
Table 89. Europe Specimen Validity Testing Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Specimen Validity Testing Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Specimen Validity Testing Revenue by Countries (2015-2020)
Table 92. South America Specimen Validity Testing Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Specimen Validity Testing Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Specimen Validity Testing Revenue Market Share by Countries (2015-2020)
Table 95. Global Specimen Validity Testing Revenue (Million USD) by Type (2015-2020)
Table 96. Global Specimen Validity Testing Revenue Share by Type (2015-2020)
Table 97. Global Specimen Validity Testing Revenue Forecast by Type (2021-2025)
Table 98. Global Specimen Validity Testing Revenue by Application (2015-2020)
Table 99. Global Specimen Validity Testing Revenue Share by Application (2015-2020)
Table 100. Global Specimen Validity Testing Revenue Forecast by Application (2021-2025)
Table 101. Global Specimen Validity Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Specimen Validity Testing Picture
Figure 2. Global Specimen Validity Testing Revenue Market Share by Type in 2019
Figure 3. Laboratory Testing Picture
Figure 4. Rapid/POC Testing Picture
Figure 5. Specimen Validity Testing Revenue Market Share by Application in 2019
Figure 6. Workplaces Picture
Figure 7. Drug Screening Laboratories Picture
Figure 8. Criminal Justice and Law Enforcement Agencies Picture
Figure 9. Pain Management Centers Picture
Figure 10. Drug Rehabilitation Centers Picture
Figure 11. Others Picture
Figure 12. Global Specimen Validity Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Specimen Validity Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Specimen Validity Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Specimen Validity Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Specimen Validity Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Specimen Validity Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Specimen Validity Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Specimen Validity Testing Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Specimen Validity Testing Revenue Market Share in 2019
Figure 21. Global Top 10 Players Specimen Validity Testing Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Specimen Validity Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Specimen Validity Testing Revenue Market Share by Regions (2015-2020)
Figure 25. Global Specimen Validity Testing Revenue Market Share by Regions in 2018
Figure 26. North America Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 27. Europe Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 29. South America Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 31. North America Specimen Validity Testing Revenue Market Share by Countries (2015-2020)
Figure 32. North America Specimen Validity Testing Revenue Market Share by Countries in 2019
Figure 33. USA Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 34. Canada Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 36. Europe Specimen Validity Testing Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Specimen Validity Testing Revenue Market Share by Countries in 2019
Figure 38. Germany Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 39. UK Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 40. France Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 41. Russia Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 42. Italy Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Specimen Validity Testing Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Specimen Validity Testing Revenue Market Share by Countries in 2019
Figure 45. China Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 46. Japan Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 47. Korea Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 48. India Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 50. South America Specimen Validity Testing Revenue Market Share by Countries (2015-2020)
Figure 51. South America Specimen Validity Testing Revenue Market Share by Countries in 2019
Figure 52. Brazil Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Specimen Validity Testing Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Specimen Validity Testing Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 57. UAE Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Specimen Validity Testing Revenue and Growth Rate (2015-2020)
Figure 60. Global Specimen Validity Testing Revenue Share by Type (2015-2020)
Figure 61. Global Specimen Validity Testing Revenue Share by Type in 2019
Figure 62. Global Specimen Validity Testing Market Share Forecast by Type (2021-2025)
Figure 63. Global Laboratory Testing Revenue Growth Rate (2015-2020)
Figure 64. Global Rapid/POC Testing Revenue Growth Rate (2015-2020)
Figure 65. Global Specimen Validity Testing Revenue Share by Application (2015-2020)
Figure 66. Global Specimen Validity Testing Revenue Share by Application in 2019
Figure 67. Global Specimen Validity Testing Market Share Forecast by Application (2021-2025)
Figure 68. Global Workplaces Revenue Growth Rate (2015-2020)
Figure 69. Global Drug Screening Laboratories Revenue Growth Rate (2015-2020)
Figure 70. Global Criminal Justice and Law Enforcement Agencies Revenue Growth Rate (2015-2020)
Figure 71. Global Pain Management Centers Revenue Growth Rate (2015-2020)
Figure 72. Global Drug Rehabilitation Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Specimen Validity Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Specimen Validity Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Specimen Validity Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Specimen Validity Testing Revenue Market Forecast (2021-2025)
Figure 78. Europe Specimen Validity Testing Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Specimen Validity Testing Revenue Market Forecast (2021-2025)
Figure 80. South America Specimen Validity Testing Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Specimen Validity Testing Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---